180 Wealth Advisors LLC Has $218,000 Stake in McKesson Co. (NYSE:MCK)

180 Wealth Advisors LLC decreased its holdings in shares of McKesson Co. (NYSE:MCK) by 69.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 382 shares of the company’s stock after selling 850 shares during the quarter. 180 Wealth Advisors LLC’s holdings in McKesson were worth $218,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in MCK. Oppenheimer Asset Management Inc. boosted its holdings in McKesson by 140.3% during the second quarter. Oppenheimer Asset Management Inc. now owns 2,992 shares of the company’s stock worth $1,747,000 after purchasing an additional 1,747 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in McKesson by 5.8% in the second quarter. Dimensional Fund Advisors LP now owns 395,150 shares of the company’s stock valued at $230,821,000 after acquiring an additional 21,832 shares during the last quarter. Citizens Financial Group Inc. RI lifted its stake in McKesson by 88.6% in the second quarter. Citizens Financial Group Inc. RI now owns 1,858 shares of the company’s stock valued at $1,086,000 after acquiring an additional 873 shares during the last quarter. WealthPLAN Partners LLC lifted its stake in McKesson by 23.5% in the second quarter. WealthPLAN Partners LLC now owns 1,363 shares of the company’s stock valued at $796,000 after acquiring an additional 259 shares during the last quarter. Finally, Moors & Cabot Inc. lifted its stake in McKesson by 7.1% in the second quarter. Moors & Cabot Inc. now owns 2,448 shares of the company’s stock valued at $1,430,000 after acquiring an additional 163 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Wells Fargo & Company increased their price target on shares of McKesson from $535.00 to $641.00 and gave the company an “equal weight” rating in a research note on Friday, December 13th. Robert W. Baird upgraded shares of McKesson from a “neutral” rating to an “outperform” rating and increased their price target for the company from $531.00 to $688.00 in a research note on Thursday, November 7th. Deutsche Bank Aktiengesellschaft cut their price target on shares of McKesson from $623.00 to $579.00 and set a “buy” rating for the company in a research note on Wednesday, September 25th. Leerink Partners dropped their price objective on shares of McKesson from $665.00 to $630.00 and set an “outperform” rating on the stock in a research report on Monday, October 7th. Finally, Bank of America dropped their price objective on shares of McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $646.14.

McKesson Stock Down 1.7 %

NYSE:MCK opened at $583.51 on Thursday. The company has a fifty day moving average of $595.09 and a 200-day moving average of $560.90. The firm has a market capitalization of $74.07 billion, a P/E ratio of 30.22, a P/E/G ratio of 1.25 and a beta of 0.52. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $637.51.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating the consensus estimate of $6.88 by $0.19. The company had revenue of $93.65 billion during the quarter, compared to analyst estimates of $89.33 billion. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. McKesson’s revenue for the quarter was up 21.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.23 EPS. On average, analysts anticipate that McKesson Co. will post 32.73 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd were paid a $0.71 dividend. The ex-dividend date was Monday, December 2nd. This represents a $2.84 annualized dividend and a dividend yield of 0.49%. McKesson’s dividend payout ratio is currently 14.71%.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Leann B. Smith sold 579 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the completion of the sale, the executive vice president now owns 864 shares in the company, valued at approximately $494,890.56. The trade was a 40.12 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.11% of the stock is currently owned by company insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.